Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating expenses
Research and development	$ 1,451,236	$ 470,976
General and administrative	2,613,093	1,403,465
Total operating expenses	4,064,329	1,874,441
Operating loss	(4,064,329)	(1,874,441)
Other income (expense)	(8,978)	59
Loss before income taxes	(4,073,307)	(1,874,382)
Income taxes	0	0
Net loss	$ (4,073,307)	$ (1,874,382)
Loss per common share - basic and diluted (in dollars per share)	$ (0.62)	$ (8.48)
Weighted average shares outstanding - basic and diluted (in shares)	6,565,514	220,996